RESEARCH PEPTIDE
CJC-1295 DAC 5MG
Albumin-Binding GHRH Analog for Endocrine Research
CJC-1295 with DAC is a modified growth hormone-releasing hormone analog developed with an albumin-binding drug affinity complex. Published research has examined how this modification changes the duration of exposure and signaling through the GHRH receptor.
Controlled research may compare receptor activity, peptide stability and endocrine signaling with other GHRH analogs. The DAC form is distinct from products labeled no DAC; findings for one form should not be assumed to apply to the other. This material is supplied for laboratory, analytical and research use only.
LEGAL DISCLAIMER: This product is intended strictly for research, laboratory or analytical purposes only. It is not intended for human consumption, veterinary use, medical applications or any unapproved use. This product has not been evaluated by the Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure or prevent any disease or medical condition. For use by qualified research professionals only.
COAs
Open the Certificate of Analysis for this research product below.
Each report applies only to the identified sample or lot. Confirm that the identity and presentation match the material you intend to purchase; results do not establish sterility or clinical suitability.
